Dxc Technology Company
—- Market cap
- —
- Debt
- +$3.30B
- Cash
- −$1.74B
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: DXC stock price vs DT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DT's multiple
Needs DT P/E.
Implied fair value · at DXC's multiple
Needs DXC P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DXC FY 2026 (ended Mar 31, 2026) · DT FY 2026 (ended Mar 31, 2026).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
DXC TECHNOLOGY COMPANY · implied price per share
Bear
$56.24
Base
$66.17
Bull
$76.09
Dynatrace, Inc. · implied price per share
Bear
$9.13
Base
$10.74
Bull
$12.35
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.12x
0.11x
Net debt / EBITDA
Leverage against operating earnings
0.83x
-2.78x
Cash and equivalents
Liquid reserves on the balance sheet
$1.74B
$1.19B
Total debt
Interest-bearing obligations outstanding
$3.30B
$283.42M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
DXC vs ACN
INTERNATIONAL BUSINESS MACHINES CORP
DXC vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
DXC vs CTSH
EPAM Systems, Inc.
DXC vs EPAM
Genpact LTD
DXC vs G
UNISYS CORP
DXC vs UIS
Salesforce, Inc.
DXC vs CRM
ADOBE INC.
DXC vs ADBE
ORACLE CORP
DXC vs ORCL
MICROSOFT CORP
DXC vs MSFT
CISCO SYSTEMS, INC.
DXC vs CSCO
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe DXC can reaccelerate growth and improve profitability without increasing leverage, then a value-oriented long could make sense because the shares trade near the bottom of the historical range and at very low sales multiples; otherwise, the weaker growth, margins, and Altman Z-Score argue for caution versus DT.
On the provided P/E-based framework, DXC's current price of $9.91 is above the implied price of $8.29, implying 16.3% downside. The market is effectively pricing DXC at very low sales and EBITDA multiples, but that discount is paired with materially weaker growth and margin quality than DT.
Supporting Metrics